Axsome Therapeutics Inc (AXSM)

03:08 AM

Historical volatility pattern of Axsome Therapeutics Inc. visualizedWall Street Watch & Long-Term Investment Growth Plans - newser.com

03:08 AM

02:13 AM

6,000 Shares in Axsome Therapeutics, Inc. $AXSM Acquired by Knott David M Jr - MarketBeat

02:13 AM

01:35 AM

Is Axsome Therapeutics Inc. (19X) stock safe for risk averse investorsQuarterly Trade Summary & Real-Time Sentiment Analysis - newser.com

01:35 AM

06:46 AM

Is Axsome Therapeutics Inc. (19X) stock positioned for digital growth eraMarket Sentiment Review & Safe Capital Preservation Plans - newser.com

06:46 AM

Nov 17, 2025

Axsome Therapeutics stock hits all-time high at 144.19 USD By Investing.com - Investing.com Nigeria

Nov 17, 2025

Nov 17, 2025

Axsome Therapeutics stock hits all-time high at 144.19 USD - Investing.com India

Nov 17, 2025

Nov 17, 2025

Will Axsome Therapeutics Inc. stock go up soonJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com

Nov 17, 2025

Nov 17, 2025

Envestnet Asset Management Inc. Grows Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Nov 17, 2025

Nov 17, 2025

Bank of New York Mellon Corp Has $21.26 Million Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Nov 17, 2025

Nov 17, 2025

Tools to assess Axsome Therapeutics Inc.’s risk profile2025 Market Sentiment & Fast Moving Trade Plans - newser.com

Nov 17, 2025

Nov 17, 2025

How Axsome Therapeutics Inc. stock compares to industry benchmarksProfit Target & Fast Gaining Stock Strategy Reports - newser.com

Nov 17, 2025

Nov 16, 2025

How Axsome Therapeutics Inc. stock performs in rate cut cyclesPortfolio Risk Summary & Technical Pattern Based Buy Signals - newser.com

Nov 16, 2025

Nov 16, 2025

Axsome Therapeutics, Inc. $AXSM Shares Purchased by Los Angeles Capital Management LLC - MarketBeat

Nov 16, 2025

Nov 16, 2025

Candriam S.C.A. Trims Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Nov 16, 2025

Nov 15, 2025

Axsome Therapeutics Inc. stock momentum explainedEarnings Risk Report & Safe Entry Zone Identification - newser.com

Nov 15, 2025

Nov 15, 2025

(AXSM) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com

Nov 15, 2025

Nov 15, 2025

What Wall Street predicts for Axsome Therapeutics Inc. stock priceGap Up & Free Technical Confirmation Trade Alerts - newser.com

Nov 15, 2025

Nov 15, 2025

Can machine learning forecast Axsome Therapeutics Inc. recoveryJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 15, 2025

Nov 15, 2025

How rising interest rates impact Axsome Therapeutics Inc. stock2025 Sector Review & Community Shared Stock Ideas - newser.com

Nov 15, 2025

Nov 15, 2025

Market reaction to Axsome Therapeutics Inc.’s recent newsInsider Selling & Low Risk High Win Rate Stock Picks - newser.com

Nov 15, 2025

Nov 14, 2025

Axsome Therapeutics Inc. recovery potential after sell offJuly 2025 Drop Watch & Community Shared Stock Ideas - newser.com

Nov 14, 2025

Nov 14, 2025

Why analysts recommend Axsome Therapeutics Inc. (19X) stock2025 Key Lessons & Daily Price Action Insights - Fundação Cultural do Pará

Nov 14, 2025

Nov 14, 2025

How Axsome Therapeutics Inc. (19X) stock reacts to Fed tighteningVolume Spike & Community Trade Idea Sharing - newser.com

Nov 14, 2025

Nov 14, 2025

Campbell & CO Investment Adviser LLC Purchases New Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Nov 14, 2025

Nov 14, 2025

Will Axsome Therapeutics Inc. stock sustain high P E ratios2025 Investor Takeaways & Daily Entry Point Trade Alerts - newser.com

Nov 14, 2025

Nov 13, 2025

How Axsome Therapeutics Inc. (19X) stock trades pre earningsM&A Rumor & Verified Swing Trading Watchlists - newser.com

Nov 13, 2025

Nov 13, 2025

Axsome Therapeutics (NASDAQ:AXSM) Hits New 12-Month HighWhat's Next? - MarketBeat

Nov 13, 2025

Nov 12, 2025

What candlestick patterns are forming on Axsome Therapeutics Inc.Gold Moves & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 12, 2025

Nov 12, 2025

Avenue Therapeutics Sells Baergic Bio to Axsome - TipRanks

Nov 12, 2025

Nov 12, 2025

RBC Capital Sticks to Their Buy Rating for Axsome Therapeutics (AXSM) - The Globe and Mail

Nov 12, 2025

Nov 11, 2025

Claim your share of the $7.75M Axsome Therapeutics securities class action settlement - Claim Depot

Nov 11, 2025

Nov 11, 2025

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 11, 2025

Nov 11, 2025

Is Axsome Therapeutics Inc. stock a buy on dipsJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com

Nov 11, 2025

Nov 10, 2025

Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Axsome Therapeutics, Inc. Common StockAXSM - Markets Financial Content

Nov 10, 2025

Nov 10, 2025

Axsome Therapeutics acquires Baergic Bio from Avenue Therapeutics - MSN

Nov 10, 2025

Nov 10, 2025

2 Monster Stocks in the Making - Nasdaq

Nov 10, 2025

Nov 10, 2025

Connor Clark & Lunn Investment Management Ltd. Increases Stock Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Nov 10, 2025

Nov 10, 2025

Can Axsome Therapeutics Inc. stock continue upward trendJuly 2025 Retail & Advanced Technical Signal Analysis - newser.com

Nov 10, 2025

Nov 10, 2025

Why hedge funds are buying Axsome Therapeutics Inc. stockJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com

Nov 10, 2025

Nov 10, 2025

Axsome Therapeutics Inc. stock trend forecastJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - newser.com

Nov 10, 2025